Literature DB >> 10574463

Molecular cloning and functional characterization of the upstream promoter region of the human p73 gene.

Y Ding1, T Inoue, J Kamiyama, Y Tamura, N Ohtani-Fujita, E Igata, T Sakai.   

Abstract

The p73 gene encodes a protein that shares structural and functional homologies with the p53 tumor suppressor protein. To investigate the mechanism of transcriptional regulation of the p73 gene, we isolated a genomic DNA fragment spanning the 5' upstream region of the human p73 gene and characterized the promoter region. Unlike the p53 gene promoter, the human p73 gene promoter contained a putative TATA-box, and did not exhibit any extended homology to the p53 gene. Two CpG islands were located in the 5' upstream region. Transient transfection assays using progressive truncations of the p73 promoter showed that deletion from -119 to +19 relative to exon 1 resulted in a 13- to 20-fold reduction in the p73 promoter activity, suggesting that the elements for basal promoter activity exist in this region, where putative Sp1, AP-2 and Egr-1, 2, 3 sites are located and CpG dinucleotides are especially concentrated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574463     DOI: 10.1093/dnares/6.5.347

Source DB:  PubMed          Journal:  DNA Res        ISSN: 1340-2838            Impact factor:   4.458


  12 in total

1.  The human p73 promoter: characterization and identification of functional E2F binding sites.

Authors:  Ratnam S Seelan; Meredith Irwin; Petra van der Stoop; Chiping Qian; William G Kaelin; Wanguo Liu
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Virtual genome scan: a tool for restriction landmark-based scanning of the human genome.

Authors:  J M Rouillard; A E Erson; R Kuick; J Asakawa ; K Wimmer; M Muleris; E M Petty; S Hanash
Journal:  Genome Res       Date:  2001-08       Impact factor: 9.043

3.  DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.

Authors:  Mirko Marabese; Faina Vikhanskaya; Cristina Rainelli; Toshiyuki Sakai; Massimo Broggini
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

4.  Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Authors:  Samir Benosman; Xiangjun Meng; Yannick Von Grabowiecki; Lavinia Palamiuc; Lucian Hritcu; Isabelle Gross; Georg Mellitzer; Yoichi Taya; Jean-Philippe Loeffler; Christian Gaiddon
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

5.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

Review 6.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

7.  The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation.

Authors:  G Fontemaggi; A Gurtner; S Strano; Y Higashi; A Sacchi; G Piaggio; G Blandino
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 8.  The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Authors:  V Baron; E D Adamson; A Calogero; G Ragona; D Mercola
Journal:  Cancer Gene Ther       Date:  2006-02       Impact factor: 5.987

9.  p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.

Authors:  Chaitali Tophkhane; Shi-He Yang; Yunbo Jiang; Zhikun Ma; Dharmalingam Subramaniam; Shrikant Anant; Shingo Yogosawa; Toshiyuki Sakai; Wan-Guo Liu; Susan Edgerton; Ann Thor; Xiaohe Yang
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

10.  Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis.

Authors:  Melda Tozluoğlu; Ezgi Karaca; Turkan Haliloglu; Ruth Nussinov
Journal:  Nucleic Acids Res       Date:  2008-07-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.